Pediatrix Medical Group, Inc. (MD) Stock
Key stats
- Market cap
- $2.46B
- Price / Earnings ratio
- 16.5x
- EPS (TTM)
- $1.89
- Volume
- Loading
- 52-week high
- $33.74
- 52-week low
- $17.23
Source: third-party data provider, as of November 13, 2026
Compare with MD
Recent news
What Pediatrix Medical Group (MD) Said on Its Q3 Earnings Call
What Pediatrix Medical Group (MD) Said on Its Q3 Earnings Call
MD
Pediatrix Medical Group (MD) Beats Q3 Earnings and Revenue Estimates
Pediatrix Medical Group (MD) Beats Q3 Earnings and Revenue Estimates
MD
Pediatrix Medical Group Reports Third Quarter Results
Pediatrix Medical Group Reports Third Quarter Results
MD
Pediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026
Pediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026
MDNews tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 66.55
- MACD 12/26/9
- 1.25
- EMA 9 of MACD
- 1.13
- MACD histogram
- 0.12
- SMA 50
- $27.71
- Price above SMA 50
- EMA 50
- $28.32
- Price above EMA 50
- SMA 200
- $24.26
- Price above SMA 200
- EMA 200
- $24.91
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 3 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $0.56 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news
What Pediatrix Medical Group (MD) Said on Its Q3 Earnings Call
What Pediatrix Medical Group (MD) Said on Its Q3 Earnings Call
MDPediatrix Medical Group (MD) Beats Q3 Earnings and Revenue Estimates
Pediatrix Medical Group (MD) Beats Q3 Earnings and Revenue Estimates
MDPediatrix Medical Group Reports Third Quarter Results
Pediatrix Medical Group Reports Third Quarter Results
MDPediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026
Pediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026
MD
Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term
Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term
MD
HB Wealth Expands Into Texas With Experienced Three-Advisor Team
HB Wealth Expands Into Texas With Experienced Three-Advisor Team
MD
Can Pediatrix Sustain Growth Despite Lower Patient Volumes?
Can Pediatrix Sustain Growth Despite Lower Patient Volumes?
MD
Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term
Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term
MD
Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?
Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?
MD
Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?
Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?
MDNews tone: automated (AI) classification of the article's content, not a price prediction.
About Pediatrix Medical Group, Inc.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Mark S. Ordan | CEO & Executive Chairman | 1959 |
| Ms. Kasandra H. Rossi | Executive VP, Treasurer & CFO | 1973 |
| Mr. D. Gregory Neeb | Executive VP & Chief Operating and Strategy Officer | 1968 |
| Ms. Mary Ann E. Moore J.D. | Advisor | 1960 |
| Mr. John C. Pepia | Senior VP & Chief Accounting Officer | 1963 |
| Ms. Cheryl M. VanPatten | Senior VP & Chief Information Officer | — |
| Mr. David Haddock | Executive Vice President, General Counsel & Secretary | — |
| Ms. Debra McRoberts | Senior Vice President of People Services | — |
| Mr. Kevin Pitzer | President of West Division | — |
| Mr. Mike Ashford | President of South Central Division | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 66.55
- MACD 12/26/9
- 1.25
- EMA 9 of MACD
- 1.13
- MACD histogram
- 0.12
- SMA 50
- $27.71
- Price above SMA 50
- EMA 50
- $28.32
- Price above EMA 50
- SMA 200
- $24.26
- Price above SMA 200
- EMA 200
- $24.91
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
3 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $28.00
- Average
- $29.00
- High
- $31.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -12.3 | +11.4 | ||||||||||
| 2022 | -11.7 | -3.1 | +2.3 | -22.9 | +1.6 | +10.2 | +3.1 | -23.0 | -6.7 | +14.7 | -18.2 | -8.5 |
| 2023 | +2.2 | -0.1 | -3.5 | -3.9 | -7.2 | +4.8 | -1.5 | +3.4 | -9.0 | -10.5 | -25.2 | +6.0 |
| 2024 | -0.2 | -4.7 | +14.4 | -8.9 | -18.9 | +1.8 | +17.3 | +31.6 | +8.7 | +2.7 | -1.6 | -12.6 |
| 2025 | +7.3 | +6.1 | -0.1 | -11.2 | +11.1 | +6.0 | -14.5 | +43.7 | -0.8 | -0.2 | +14.3 | -11.2 |
| 2026 | +0.4 | -7.4 | +9.3 | +8.7 | -5.3 | +17.2 | +1.4 | -0.1 | -2.8 | +15.8 | +2.4 |
